Navigation Links
ADVENTRX Provides Update on All Three Pipeline Products
Date:8/30/2011

SAN DIEGO, Aug. 30, 2011 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today provided an update on its planned meetings with the U.S. Food and Drug Administration (FDA) regarding its three late-stage programs:

Exelbine (vinorelbine injectable emulsion)

  • Type A meeting with FDA has been requested.  This meeting is to discuss the complete response letter regarding the Company's New Drug Application (NDA) for Exelbine.  The Company will present information that it believes demonstrates the authenticity of study drugs used in the pivotal study.  

ANX-514 (docetaxel for injectable emulsion)

  • Type B clinical meeting with FDA has been requested.  This meeting is to discuss the pivotal safety study that FDA recommended at a meeting earlier this year.  The Company is proposing a randomized, open-label study designed to descriptively evaluate the safety of ANX-514 without corticosteroid premedication and Taxotere® with corticosteroid premedication in non-small cell lung cancer.  
  • Type B CMC meeting with FDA has been requested.  This meeting is to discuss the manufacture of ANX-514 for clinical trial material in connection with the planned pivotal safety study and for commercial product.

ANX-188 (purified poloxomer 188)

  • Type B clinical meeting with FDA is planned for the fourth quarter of 2011.  This meeting will be to confirm prior agreements with FDA, reach agreement on key aspects of the planned phase 3 pediatric study in sickle cell crisis and discuss the overall development plan.  
  • Type B CMC meeting with FDA is planned for the first quarter of 2012.  This meeting will be to discuss the manufacture of ANX-188 for clinical trial material
    '/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Reports Second Quarter 2011 Financial Results
2. ADVENTRX Pharmaceuticals to Present at the 31st Annual Canaccord Genuity Growth Conference on August 11
3. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
4. ADVENTRX Reports First Quarter 2011 Financial Results
5. ADVENTRX Completes Acquisition of SynthRx
6. ADVENTRX Pharmaceuticals Provides Update on ANX-514
7. ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
8. ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts
9. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
10. ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine™ NDA
11. ADVENTRX Pharmaceuticals Announces Closing of $22.5 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... WYNNEWOOD, Pa. , Jan. 23, 2015  MedScope ( ... has been nominated for a 2015 Connected World ... Personal Emergency Response System (mPERS), that can be used ... M2M technology partner.  In nominating MedScope, ...
(Date:1/23/2015)... , Jan. 23, 2015  Pete Rose, baseball,s all-time hits ... and arthritis pain reliever Myoflex, Ducere Pharma has announced. ... we are excited to have him on board with Myoflex," ... "He is a legendary player who is known across all ...
(Date:1/23/2015)... SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, ... where its Phase I trial of Lixte,s lead compound, LB‑100, ... institutions. John S. Kovach , M.D., the ... was planned to be completed at a single site. Accrual ...
Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... Premature Births, WATSONVILLE, Calif., Feb. 5 The ... acid supplements greatly,reduced the risk of premature birth. Meanwhile, ... supplements., It,s often hard for people to remember ... benefit from this B vitamin need only visit their,supermarket,s ...
... Feb. 5 Researchers are,identifying innovative therapeutics for ... the disease,s progression, such as the important role,of ... a study prepublished,online in Blood, the official journal ... molecule therapy called senicapoc showed efficacy,in maintaining hydration ...
Cached Medicine Technology:Folate in Strawberries May Contribute to Healthy Pregnancy 2Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells 2Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells 3
(Date:1/22/2015)... (PRWEB) January 22, 2015 Deer Path of ... host a Valentine’s Day Happy Hour from 3 p.m. to 4 ... 12500 Regency Parkway in Huntley, Illinois, serves adults with physical disabilities ... event will include Valentine's Day treats, games and sweetheart-themed karaoke. , ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort ... TripAdvisor as the number one best large hotel for families ... world for their annual Travelers’ Choice Awards. , TripAdvisor ... website is home to millions of unbiased and honest traveler ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many ... it on Facebook, Twitter, and Pinterest. The fans will have ... a lottery every week. , Moreover, the company has extended ... Angelweddingdress homepage for more information. , Angelweddingdress ...
(Date:1/22/2015)... A new white paper by The Beryl Institute ... long-term care environment as well as provides recommendations for ... “The Power of Person-Centeredness in Long-Term Care: A View ... patient, resident and family experience in long-term care and ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved ... upcoming 32nd Annual Miami Breast Cancer Conference ... LLC (PER®) , shares that “a fast-growing, virulent” cancer ... she had not followed up her clean mammogram with ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... Low Donation Rates, Encourage New,York Blood Donor Diversity, ... New York,Blood Center (NYBC), the nation,s largest community-based, ... blood "donor,coach," funded by a $160,000 grant from ... MetLife,s mascot, making it an,eye-catching reminder, in the ...
... 20 BioForm Medical,Inc. (Nasdaq: BFRM ) ... BioForm Medical will present a company overview at ... June 24-26th, 2008,in New York. BioForm Medical,s presentation ... 8:30 a.m. EDT., A live and archived ...
... Appeal Hearing, TORONTO, June 20 /PRNewswire-FirstCall/ - ... today announced the successful completion,of its agreement with ... a result of the completion of this project, ... company for further product development and,other skin testing ...
... Finnish study urges this 3rd category be added ... 20 (HealthDay News) -- Hazardous drinking -- drinking ... needs to be recognized as a genuine public ... disorders are divided into two categories: alcohol abuse/harmful ...
... of lesions seen on MRIs with limited side effects, study ... the first pills to treat the "relapse-remitting" form of multiple ... few side effects. , Although the drug, laquinimod, is still ... convenient for many patients. , "By and large, this doesn,t ...
... June 20 From June 20, 2008 through,June 27, ... around the,United States and the world will gather at ... Little People of America (LPA),Conference in downtown Detroit., ... the City of,Detroit to bring global solutions and awareness ...
Cached Medicine News:Health News:MetLife Foundation Partners with New York Blood Center to Introduce 'Donor Coach' to New York Boroughs 2Health News:MetLife Foundation Partners with New York Blood Center to Introduce 'Donor Coach' to New York Boroughs 3Health News:PreMD Successfully Completes Project for Health & Beauty Company 2Health News:'Hazardous Drinking' More Common Than Thought 2Health News:Experimental Drug Fights Multiple Sclerosis Activity 2Health News:Experimental Drug Fights Multiple Sclerosis Activity 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: